Verdiva Bio Dev

A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight

Phase 1, Recruiting, 2026, 336 people, 4 Jun 2026, clinicaltrials.gov

A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Phase 2, Active, not recruiting, 2026, 120 people, 28 Apr 2026, clinicaltrials.gov

NCT07281937

Phase 2, Completed, 2025, 206 people, 15 Dec 2025, clinicaltrials.gov